Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aldans Health is an early-stage neurotechnology startup developing a non-invasive neuromodulation device for neurological and stress-related conditions. Its lead product, the ANTIS DMS Stimulator Pillow, uses low-field gamma-rhythmic magnetic stimulation intended to reach deep brain structures and enhance hippocampal function and adult hippocampal neurogenesis. Publicly available descriptions position the company around applications in traumatic brain injury and chronic stress rather than traditional drug development. Aldans appears to collaborate with scientists across China, Canada, and the United States. Based on available evidence, the company is best characterized as a private, preclinical medical-device/neurotech company rather than a conventional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aldans Health.